Luteolin induces apoptosis through endoplasmic reticulum stress and mitochondrial dysfunction in Neuro-2a mouse

A Young Choi1, Ji Hyun Choi, Hana Yoon

  • 1Department of Biochemistry and Molecular Biology, School of Medicine, Medical Science and Engineering Research Center for Bioreaction to Reactive Oxygen Species, Biomedical Science Institute, Kyung Hee University, Seoul 130-701, Republic of Korea.

Insights

Luteolin, a dietary flavonoid, triggers apoptosis in neuroblastoma cells by inducing endoplasmic reticulum stress and mitochondrial dysfunction. This research clarifies luteolin

Area of Science:

  • Oncology
  • Neuroscience
  • Molecular Biology

Background:

  • Luteolin, a dietary flavonoid, exhibits anti-cancer properties against various cancer types.
  • The precise mechanisms of luteolin's anti-cancer effects in neuroblastoma remain incompletely understood.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying luteolin's anti-cancer effects in Neuro-2a mouse neuroblastoma cells.

Main Methods:

  • Investigated luteolin's effects on apoptosis, endoplasmic reticulum (ER) stress markers, reactive oxygen species (ROS) generation, and mitochondrial function.
  • Utilized siRNA for gene knockdown (caspase-12, CHOP) and employed chemical inhibitors (4-phenylbutyric acid, N-acetylcysteine, MAPK inhibitors).
  • Assessed activation of caspases, ER stress proteins (CHOP, GRP78, ATF6α, eIF2α), mitochondrial membrane potential, and mitogen-activated protein kinases (MAPKs).

Main Results:

  • Luteolin induced apoptosis via caspase activation (caspase-12, -9, -3) and ER stress, evidenced by increased CHOP, GRP78, ATF6α cleavage, and eIF2α phosphorylation.
  • Luteolin triggered ROS accumulation and mitochondrial dysfunction, indicated by reduced mitochondrial membrane potential and Bax translocation.
  • MAPK pathways (JNK, p38, ERK) were activated by luteolin, contributing to cell death and mitochondrial events.

Conclusions:

  • Luteolin induces apoptosis in neuroblastoma cells through a mechanism involving ER stress and mitochondrial dysfunction.
  • The findings highlight the potential of luteolin as a therapeutic agent for neuroblastoma, warranting further investigation.